Clinical Utility of Selinexor/Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma: A Review of Current Evidence and Patient Selection

Panagiotis Malandrakis,* Ioannis Ntanasis-Stathopoulos,* Maria Gavriatopoulou, Evangelos Terpos Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece*These authors contributed equally to this workCorrespondence: Evangelos TerposDepart...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Malandrakis P, Ntanasis-Stathopoulos I, Gavriatopoulou M, Terpos E
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove Medical Press 2020-07-01
Serie:OncoTargets and Therapy
Ämnen:
selinexor
exportin
selective inhibitor of nuclear export
relapsed/refractory
myeloma
Länkar:https://www.dovepress.com/clinical-utility-of-selinexordexamethasone-in-patients-with-relapsed-o-peer-reviewed-article-OTT
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk